Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may halt the deacetylation of histone proteins, leading to a hyperacetylated chromatin state that could constrain the transcription machinery's access to the OR52M1 gene, resulting in decreased expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could lead to hypomethylation of the OR52M1 gene promoter. This change may downregulate transcriptional initiation, thereby reducing the gene's expression levels. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds selectively to GC-rich DNA sequences, which may obstruct transcription factor binding sites on the OR52M1 gene promoter, leading to a decrease in OR52M1 transcriptional activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin (Sirolimus) may suppress mTOR pathway signaling, which is crucial for cap-dependent translation initiation. This suppression could contribute to a reduction in the synthesis of the OR52M1 protein. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine′s interference with endosomal and lysosomal acidification could disrupt cellular signaling cascades that are essential for the transcriptional activation of the OR52M1 gene, thereby reducing its expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to its nuclear receptors, which may lead to altered expression of genes, including OR52M1. If retinoic acid disrupts transcriptional enhancers of OR52M1, it could result in its decreased expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide may inhibit the activity of RNA polymerase II, a critical enzyme for mRNA synthesis. This inhibition could directly lead to a decrease in the transcription levels of the OR52M1 gene. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may intercalate into DNA, thereby obstructing the elongation phase of RNA polymerase during mRNA synthesis. This blockage could result in reduced levels of OR52M1 mRNA. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 may inhibit MEK1/2 enzymes, which are part of the MAPK/ERK pathway. Inhibition of this pathway could lead to the downregulation of transcription factors that promote OR52M1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may inhibit the PI3K/Akt signaling pathway, which could lead to a decrease in transcription factors or coactivators necessary for the expression of the OR52M1 gene, resulting in its lower expression levels. | ||||||